高级检索
当前位置: 首页 > 详情页

Bisacurone attenuates diabetic nephropathy by ameliorating oxidative stress, inflammation and apoptosis in rats

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Zhengzhou Univ, Zhengzhou Cent Hosp, Dept Tradit Chinese Med, Zhengzhou, Peoples R China [2]Tianjing Med Univ, Clin Med, Tianjin, Peoples R China [3]Hebei Univ,Affiliated Hosp,Dept Nephrol,212 Yuhua Rd,Baoding 071002,Hebei,Peoples R China
出处:
ISSN:

关键词: Bisacurone hyperglycemia oxidative stress inflammation apoptosis

摘要:
BackgroundDiabetes nephropathy (DN) is a serious diabetic problem that may progress to renal failure. The root of Curcuma longa L., often known as turmeric, provides various health benefits. Bisacurone is a bioactive terpenoid found in small amounts in turmeric that possesses anti-inflammatory and antioxidant properties. The present study focuses on the potential protective effects of bisacurone against DN via reducing renal inflammation, oxidative stress, and apoptosis.MethodsType 2 diabetes was created in rats by feeding them a high-fat/high-sugar diet for 8 weeks, followed by a low dose of streptozotocin and Bisacurone (50 and 100 mu g/kg bisacurone) given for 4 weeks.ResultsIn diabetic rats, bisacurone reduced hyperglycemia, protected against body weight (BW) loss, lowered renal markers, reduced lipid profile alterations and avoided histological abnormalities. Bisacurone treatment reduced oxidative stress by decreasing malondialdehyde (MDA) levels while enhancing antioxidant defenses through superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) levels. Furthermore, bisacurone treatment activated the renal Nrf2/Keap1 signaling pathway but attenuated the high levels of NF kappa B p65, TNF-alpha, IL-1 beta, IL-6, Cox2, and iNOS. Bisacurone also reduced Bax, caspase-3, caspase-9 and cytochrome c but increased Bcl-2 in the kidneys of diabetic rats.ConclusionIn the present study, bisacurone reduces DN by reducing hyperglycemia, oxidative stress, inflammation, and apoptosis, while also increasing Nrf2/HO-1 signaling.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 毒理学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 毒理学
JCR分区:
出版当年[2022]版:
Q3 TOXICOLOGY
最新[2023]版:
Q3 TOXICOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Zhengzhou Univ, Zhengzhou Cent Hosp, Dept Tradit Chinese Med, Zhengzhou, Peoples R China
通讯作者:
通讯机构: [3]Hebei Univ,Affiliated Hosp,Dept Nephrol,212 Yuhua Rd,Baoding 071002,Hebei,Peoples R China [*1]Department of Nephrology, Affiliated Hospital of HebeiUniversity, No.212, Yuhua Road, Lianchi District, Baoding City , Hebei071002, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15100 今日访问量:4 总访问量:960 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号